01Available sources
Starting point
The NCI notes that finding a biomarker compatible with a therapy does not guarantee a response: other characteristics and tumor heterogeneity may influence the outcome.
Sources for this section
- Biomarker Testing for Cancer TreatmentNational Cancer Institute / NIH
02Under scientific review
What to investigate
What evidence distinguishes a useful marker for a specific decision from an association insufficient for that use?
Sources for this section
- Biomarker Testing for Cancer TreatmentNational Cancer Institute / NIH
LIMITATIONS AND CONTEXT
The scope of this reading
- Usefulness depends on the test, population and treatment. This page does not classify individual variants or recommend a therapy.
- A systematic review of supporting and opposing evidence has not yet been completed; the initial source selection is not exhaustive.
ORIGINAL READING
References and sources
- Biomarker Testing for Cancer TreatmentNational Cancer Institute / NIH
- National Cancer Institute